Synthesis of substituted 3-anilino-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepine-2-ones and their evaluation as cholecystokinin-ligands

Arch Pharm (Weinheim). 2006 Apr;339(4):163-73. doi: 10.1002/ardp.200500217.

Abstract

3-Amino-1,4-benzodiazepines as well as chemically related diverse amines were prepared from oxazepam and subsequently screened on the cholecystokinin receptor in a radiolabel binding assay. Oxazepam 2 was activated via its 3-chloro-1,4-benzodiazepine intermediate 3 and was reacted with a large series of aliphatic and aromatic amines. The substituted 3-anilino-1,4-benzodiazepine structure was identified as lead structure in a diverse series of 3-amino-1,4-benzodiazepines 4-38 and the full SAR (structure-activity relationship) optimisation provided 3-anilinobenzodiazepines 16-38 with CCK1 receptor selectivity to CCK2. The compounds 18, 24, 28 and 33 have shown affinities at the CCK1 receptor of 11, 10, 11 and 9 nM, respectively. These equipotent CCK1 ligands were fully evaluated in behaviour pharmacological essays. An antidepressant effect was identified in the tail suspension- and the Porsolt swimming-test. The ED50 values for 24 and 28 were determined in these assays as 0.46 and 0.49 mg/kg. The mixed antagonist 37 showed in addition to the antidepressant effects anxiolytic properties.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Anxiety Agents / chemical synthesis
  • Anti-Anxiety Agents / pharmacology*
  • Antidepressive Agents / chemical synthesis
  • Antidepressive Agents / pharmacology*
  • Anxiety / drug therapy
  • Benzodiazepinones / chemical synthesis
  • Benzodiazepinones / pharmacology*
  • Cerebral Cortex / metabolism
  • Depression / drug therapy
  • Disease Models, Animal
  • Guinea Pigs
  • Ligands
  • Male
  • Mice
  • Mice, Inbred ICR
  • Receptor, Cholecystokinin A / antagonists & inhibitors*
  • Solubility
  • Structure-Activity Relationship

Substances

  • Anti-Anxiety Agents
  • Antidepressive Agents
  • Benzodiazepinones
  • Ligands
  • Receptor, Cholecystokinin A